School of Medicine
Showing 12,341-12,350 of 12,884 Results
-
Lei Xing
Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization
-
Xiaojing Xing
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioXiaojing Xing is a health tech founder and product leader working at the intersection of medicine, business, and technology. She has driven AI-powered innovations across hardware and software—building from MVP to scale at both startups and global tech companies.
At Tencent, she led digital health platforms serving over 30 million users and launched AI tools that empowered 200,000+ physicians. Later, as Chief Product Officer at MindLax, she brought a neurofeedback sleep device from concept to market, growing it to thousands of users through data-driven iteration and user empathy.
Recognized on Forbes 30 Under 30 China, Xiaojing blends product management, global go-to-market strategy, and health innovation expertise. She is currently focused on applying AI to consumer health—creating intelligent, accessible technologies that make wellbeing part of everyday life.
Xiaojing holds degrees from Stanford University School of Medicine, Harvard T.H. Chan School of Public Health, and Peking University Health Science Center. -
Lulu Xing
Affiliate,
BioLulu received her undergraduate degree in Biomedicine from the University of Melbourne in Melbourne, Australia. In December 2016, Lulu was awarded a PhD degree in neuroscience from the Florey Institute of Neuroscience and Mental Health, the University of Melbourne, where she identified a major under-appreciated role for subventricular zone-derived neural precursor cells in the process of myelin regeneration after demyelinating injury. Since late 2016, Lulu worked at Australian Regenerative Medicine Institute, Monash University as a postdoctoral fellow in Dr. Tobias Merson’s group, with a focus on developing mouse models to study the molecular and cellular mechanisms underlying myelination mediated by distinct types of endogenous brain stem cells in health and disease. In particular, Lulu developed a novel mouse model of conditional OPC ablation, which could be adopted in different neurological contexts to further advance our knowledge and understanding of OPC biology. Lulu joined the Petritsch lab in late October 2022 as a research scientist, seeking to understand the role of OPCs in the development of glioma as tumour-initiating cells and how they are regulated by complex interactions with several cell types within the tumour microenvironment, using a combination of transgenic mouse models, advanced imaging techniques and single cell biology approaches.
-
Bo Xiong
Postdoctoral Scholar, Biomedical Informatics
Current Research and Scholarly InterestsAI, Foundation Models, Biomedical Data Science
-
Grace Xiong, MD
Assistant Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Xiong’s research is focused on improving the care and management of patients with subacute and chronic spinal cord injury, improving clinical outcomes in spinal surgery, and improving health access to spinal care.
-
熊剑 (Jian Xiong)
Postdoctoral Scholar, Chemical Engineering
BioI thrive to understand the roles of lysosomes in physiological and pathological conditions. Lysosomes are both degradation compartment and metabolic controlling hub, and dysregulation of lysosomal functions are frequently implicated in a vast number of diseases including neurodegenerative diseases, however, the systematic knowledge of the molecular mechanism by which lysosomal contributes to these diseases is lacking. Ion channels are the primary mediators of neuronal activity, defects in neuronal ion channel activity are linked with many kinds of neurodegenerative diseases. Interestingly, besides typical ion channels that are involved in the neuronal activity, defects in lysosomal ion channels, such as TRPML1, CLN7 and CLC-7 are also implicated in neuropathy. My previous work as Ph.D student in University of Texas MD Anderson Cancer Center focused on regulation of lysosomal function by ion channels and metabolites. I discovered a mechanism of lysosomal Na+ channel regulate mTORC1 activation by regulating lysosomal amino acid accumulation. I also discovered role of glutamine in controlling lysosomal degradation capacity. In the meantime, I developed novel methods to isolate organelles. My ultimate research goal is to understand the key developmental pathways and how alterations in gene sequences and expression contribute to human disease, therefore, I am pursuing independent academic researcher as my career goal. Starting Feb 2022, I work with Dr. Monther Abu-Remaileh at Stanford University on role of lysosomes in neurodegenerative diseases. I use genetics, chemical biology and omics approaches to study lysosome function under various physiological and pathological conditions, especially age-associated neurodegenerative disorders, and monogenic neurodegenerative lysosome storage diseases. In Stanford, I aim to integrate ionic regulation, metabolomic regulation and functional proteomic regulation to systematically understand the biology of lysosome in physiological conditions and pathological conditions.
